Occlusion Devices

Occlusion Devices Market Outlook

The global occlusion devices market is projected to reach USD 4.5 billion by 2035, growing at a CAGR of 7.8% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic diseases and the rising number of surgical procedures globally. Additionally, advancements in medical technology and the increasing adoption of minimally invasive surgical techniques are further propelling market expansion. Regulatory approvals for innovative occlusion devices and growing awareness among healthcare professionals about the benefits of these devices are some of the key factors driving market growth. The demand for effective occlusion solutions in various applications such as neurology, cardiology, and oncology is pushing manufacturers to innovate and develop new products that cater to the specific needs of healthcare providers and patients alike.

Growth Factor of the Market

The occlusion devices market is experiencing substantial growth due to several interrelated factors. One of the primary growth drivers is the increasing incidence of vascular diseases, which necessitates the use of occlusion devices for effective treatment. Additionally, the aging population is more susceptible to chronic health conditions that require surgical interventions, further elevating the demand for these devices. Technological advancements, such as the development of bioabsorbable materials and improved design features, are also making these devices more effective and easier to use. Furthermore, the growing preference for minimally invasive procedures is compelling healthcare providers to seek out innovative solutions, which is fostering a competitive environment that benefits market growth. Additionally, global collaborations among key players and investments in research and development are expected to enhance the availability and efficacy of occlusion devices on a global scale.

Key Highlights of the Market

• Projected growth rate of 7.8% CAGR over the forecast period.
• Increasing prevalence of chronic diseases driving demand for occlusion devices.
• Technological advancements enhancing the efficacy of occlusion solutions.
• Rising preference for minimally invasive surgical procedures among healthcare providers.
• Growing investments in healthcare infrastructure and R&D activities.

By Product Type

Occlusion Balloons:

Occlusion balloons are widely used in various medical procedures to temporarily block blood flow within a vessel. These devices are particularly beneficial in surgeries where controlled occlusion is needed, such as in neurology and cardiology treatments. Their design enables precise inflation and deflation, making them adaptable for various applications. The increasing number of endovascular procedures and the incorporation of advanced balloon materials are expected to drive the demand for occlusion balloons. Furthermore, innovations leading to improved patient safety and efficiency in procedures underscore their growing significance in the market.

Occlusion Coils:

Occlusion coils are another crucial segment in the occlusion devices market, primarily utilized in neurovascular surgeries to occlude blood vessels. These coils promote thrombosis and are instrumental in treating conditions like aneurysms. Their effectiveness in achieving permanent occlusion has led to their widespread acceptance among healthcare providers. The market for occlusion coils is being driven by technological advancements that enhance their delivery and placement accuracy. With ongoing research and development efforts, there is a potential for the introduction of next-generation coils that offer improved patient outcomes, further solidifying their market position.

Occlusion Plugs:

Occlusion plugs are designed to provide a secure closure of blood vessels during surgical interventions. They are particularly favored for their ability to prevent blood loss and promote optimal healing. The rising number of surgical procedures, along with the increased focus on patient safety and efficacy, is driving the demand for occlusion plugs. Moreover, advancements in material science have led to the development of plugs that are both effective and biocompatible, reducing the risk of complications. As healthcare providers continue to seek reliable solutions for vascular occlusion, the use of occlusion plugs is expected to grow significantly.

Vascular Clips:

Vascular clips are critical tools used in surgical procedures to occlude blood vessels and prevent blood flow. Their reliability and ease of use make them a preferred choice among surgeons. The increasing prevalence of cardiovascular diseases and the need for surgical interventions are propelling the growth of the vascular clips segment. Additionally, continuous innovations in clip design and material have enhanced their functionality, making them more effective in achieving desired outcomes. As the market for minimally invasive surgeries continues to expand, the demand for vascular clips is anticipated to increase correspondingly.

Liquid Embolics:

Liquid embolics have gained prominence in the occlusion devices market due to their unique properties and effectiveness in treating a variety of vascular conditions. These substances can be injected into blood vessels, facilitating targeted occlusion and allowing for precise control during procedures. The rising applications of liquid embolics in oncology and neurology are driving market growth, as they provide a minimally invasive option for patients. Continuous advancements in formulation and delivery systems are further enhancing the potential of liquid embolics, solidifying their position in the market as a viable option for clinicians.

By Application

Neurology:

In the neurology segment, occlusion devices play a crucial role in treating conditions such as aneurysms and arteriovenous malformations. The rising incidence of neurological disorders has led to increased demand for effective treatment options, thereby driving the growth of occlusion devices in this application. Minimally invasive approaches in neurovascular surgeries are gaining traction as they offer reduced recovery times and lower complication rates. As more healthcare providers adopt these techniques, the demand for specialized occlusion devices tailored for neurological applications is expected to surge, further contributing to market expansion.

Cardiology:

Cardiology is a significant application area for occlusion devices, as they are extensively used in managing various cardiovascular diseases. The growing prevalence of heart diseases globally is a major factor driving the demand for these devices. Occlusion devices are employed during interventions such as percutaneous coronary interventions (PCI) and other vascular surgeries, where controlling blood flow is critical. As technological advancements continue to improve the safety and efficacy of cardiology procedures, the occlusion devices market in this application is anticipated to witness robust growth, catering to the needs of a diverse patient population.

Oncology:

In the realm of oncology, occlusion devices are used for embolization procedures aimed at restricting blood flow to tumors, thereby inhibiting their growth. This application is becoming increasingly important as oncology treatment protocols evolve to include more targeted therapies. The rise in cancer incidences and the growing trend towards minimally invasive treatment options are significantly driving the market for occlusion devices in oncology. Continuous advancements in embolization techniques and the development of specialized products tailored for tumor treatment are expected to further bolster this segment's growth.

Peripheral Vascular Disease:

The application of occlusion devices in treating peripheral vascular diseases is gaining momentum due to the increasing prevalence of conditions such as peripheral artery disease (PAD). These devices assist in managing vascular blockages and facilitating blood flow restoration. As the global population ages and lifestyle-related health issues become more prevalent, the demand for effective treatment solutions for peripheral vascular diseases is on the rise, thus supporting the growth of the occlusion devices market. Moreover, advancements in technologies and enhanced product offerings in this segment are expected to contribute positively to market dynamics.

Others:

Other applications of occlusion devices encompass various surgical specialties where vascular occlusion is necessary. This includes procedures in fields such as urology, gastroenterology, and general surgery. The broadening scope of applications and the integration of occlusion devices into diverse surgical practices are key factors driving market growth. As practitioners across multiple specialties recognize the benefits of occlusion devices in enhancing surgical outcomes, the demand for these devices is expected to expand. Furthermore, ongoing innovations and tailored products will foster growth in this segment, meeting the evolving needs of healthcare providers.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for occlusion devices, accounting for a significant share of the market. The increasing number of surgical procedures and the focus on providing comprehensive patient care within hospital settings drive demand. Hospitals often invest in advanced occlusion technologies to ensure optimal patient outcomes, making them a pivotal channel for manufacturers. Furthermore, partnerships between hospitals and device manufacturers are fostering an environment for the introduction of innovative products tailored to meet clinical needs, further solidifying the market's growth in this segment.

Specialty Clinics:

Specialty clinics are becoming increasingly important in the distribution of occlusion devices, as they cater to specific patient needs and offer specialized services. These clinics often focus on fields such as cardiology, neurology, and oncology, where occlusion devices are critically employed. The growing preference for outpatient procedures and the rise of specialized healthcare services are contributing to the expansion of this distribution channel. Furthermore, the establishment of strategic alliances between specialty clinics and manufacturers is expected to enhance product availability and drive sales in this segment.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) have emerged as a vital distribution channel for occlusion devices, driven by the increasing trend towards outpatient surgical procedures. These centers offer cost-effective and efficient surgical options, making them attractive to patients and healthcare providers alike. The demand for minimally invasive surgeries in ASCs is propelling the use of occlusion devices, as they facilitate safer and more effective interventions. As the number of ASCs continues to grow and expand their service offerings, the market for occlusion devices in this distribution channel is expected to flourish.

Catheterization Labs:

Catheterization labs are specialized facilities equipped for interventional procedures, and they serve as an essential distribution channel for occlusion devices. The need for real-time imaging and precise delivery of occlusion products makes these labs an ideal setting for such devices. As the volume of catheter-based procedures increases, the demand for high-quality occlusion devices is expected to rise correspondingly. Furthermore, advancements in catheterization techniques and technologies will continue to enhance the effectiveness of occlusion devices used in these labs, supporting market growth.

Online Sales:

Online sales channels are gaining traction in the occlusion devices market as digital transformation reshapes the healthcare landscape. The convenience of online purchasing and the increasing trend towards e-commerce in the medical field are driving sales through these platforms. Manufacturers are leveraging digital marketing strategies to reach healthcare professionals and institutions, broadening their customer base. The rapid growth of telehealth and remote consultations is also contributing to the rise of online sales, providing an opportunity for manufacturers to enhance accessibility to occlusion devices. As more providers adopt these channels, the online distribution of occlusion devices is expected to witness significant growth.

By Material Type

Polymer:

Polymer-based occlusion devices are highly favored due to their versatility and biocompatibility. These materials can be engineered to provide specific mechanical properties and are often used in various occlusion products such as balloons and plugs. The ability of polymers to be formulated for varying degrees of flexibility and strength makes them suitable for diverse applications in surgical interventions. Furthermore, advancements in polymer technology are enhancing the performance of these devices, contributing to their growing adoption in the market. As healthcare providers continue to search for reliable and effective solutions, the demand for polymer-based occlusion devices is expected to rise.

Metal:

Metal materials are integral to the construction of many occlusion devices, such as vascular clips and coils, due to their strength and durability. The use of metal ensures a secure occlusion, making it a preferred choice among surgeons. The increasing prevalence of conditions requiring surgical intervention is driving the demand for metal-based occlusion devices. Moreover, ongoing innovations in metal alloys and surface treatments are enhancing the efficacy and safety of these devices, further solidifying their position in the market. As the need for reliable and effective occlusion solutions continues to grow, metal materials will play a crucial role in market expansion.

Bioabsorbable:

Bioabsorbable materials are gaining popularity in the occlusion devices market due to their ability to be absorbed by the body over time, eliminating the need for surgical removal. This characteristic is particularly beneficial in minimizing post-operative complications and enhancing patient recovery. The increasing adoption of bioabsorbable occlusion devices in various surgical applications reflects a growing preference for innovative solutions that prioritize patient safety and comfort. As research into bioabsorbable technologies continues to advance, the market for these devices is expected to witness significant growth, appealing to a wider range of healthcare providers.

Liquid:

Liquid materials, such as liquid embolics, are increasingly utilized in occlusion procedures due to their unique ability to conform to the target anatomy and create effective occlusion. The effectiveness of liquid embolics in treating vascular conditions, particularly in oncology and neurology, has driven their adoption among healthcare providers. The growing awareness of the benefits of liquid embolization techniques is further supporting the market growth for liquid-based occlusion devices. As innovations in this area continue to emerge, the demand for liquid materials in occlusion devices is anticipated to expand, meeting the evolving needs of clinical applications.

Others:

The "Others" category encompasses various materials used in the fabrication of occlusion devices, including combinations or specialized materials designed for specific applications. These materials may serve niche markets or cater to unique clinical needs, thereby contributing to the diversity of occlusion solutions available. The development of customized occlusion devices using innovative materials is anticipated to foster growth in this segment, as healthcare providers increasingly seek tailored solutions for patient treatment. As the market evolves, the inclusion of diverse materials is expected to enhance the overall efficacy and performance of occlusion devices.

By Region

The North American region holds a prominent position in the global occlusion devices market, accounting for approximately 40% of the total market share in 2025. The region's advanced healthcare infrastructure, coupled with the increasing prevalence of chronic diseases and rising demand for minimally invasive surgical procedures, is driving the growth of this market. Furthermore, significant investments in research and development by key market players are expected to introduce innovative occlusion devices, thereby enhancing market penetration. The United States, in particular, is leading the charge with its state-of-the-art healthcare facilities and a high standard of patient care, creating a fertile ground for market expansion.

Europe is also expected to witness substantial growth in the occlusion devices market, with a projected CAGR of 7.2% during the forecast period from 2025 to 2035. Factors such as the aging population, increased healthcare spending, and a rising awareness of advanced medical technologies are propelling the demand for occlusion devices in this region. Countries such as Germany, France, and the UK are major contributors to the market's growth, driven by robust healthcare systems and supportive regulatory frameworks. The market in Asia Pacific is also set to grow significantly, driven by rising healthcare expenditures and an increasing focus on improving healthcare access and quality.

Opportunities

As the occlusion devices market expands, numerous opportunities are emerging for manufacturers and healthcare providers alike. One of the most significant opportunities lies in the increasing focus on developing minimally invasive surgical techniques. As more hospitals and clinics adopt these procedures, the demand for effective occlusion devices that can facilitate safer and more efficient surgeries is expected to rise. Additionally, the growing prevalence of chronic diseases, such as cardiovascular conditions and cancers, presents a substantial opportunity for the market. By developing innovative occlusion solutions tailored to these specific health challenges, manufacturers can position themselves favorably in a competitive landscape. Collaborations and partnerships with healthcare providers can also enhance market reach, leading to increased sales and brand loyalty.

Furthermore, advancements in technology present ongoing opportunities for innovation within the occlusion devices sector. The integration of smart technology, such as real-time imaging and tracking systems, into occlusion devices can enhance their functionality and effectiveness. As healthcare providers seek to improve patient outcomes and minimize complications, the demand for devices equipped with cutting-edge technology will likely escalate. Moreover, the expansion of healthcare infrastructure in emerging markets is anticipated to create new avenues for growth. As awareness of the benefits of occlusion devices spreads globally, manufacturers can capitalize on this trend by targeting untapped markets and tailoring products to meet local needs.

Threats

Despite the promising growth prospects for the occlusion devices market, several threats could challenge its development. One of the primary threats is the intense competition among manufacturers, which can lead to price wars and reduced profit margins. As numerous companies strive to capture market share, the pressure to innovate and differentiate products becomes paramount. Furthermore, the rapid pace of technological advancements necessitates constant adaptation and investment in research and development, which can strain resources for smaller players in the market. Additionally, regulatory hurdles can pose challenges, as obtaining necessary approvals for new products can be a lengthy and costly process, potentially delaying market entry for innovative occlusion devices.

Another significant threat is the risk of adverse patient outcomes associated with occlusion devices, which may lead to legal challenges and damage to brand reputation. As healthcare providers prioritize patient safety, any complications arising from the use of occlusion devices could lead to increased scrutiny and regulatory action. Moreover, the ongoing shift towards value-based healthcare may put pressure on manufacturers to demonstrate the efficacy and cost-effectiveness of their products. As reimbursement models evolve, manufacturers may face challenges in securing favorable payment terms, impacting overall sales. Addressing these threats will require a proactive approach focused on innovation, quality assurance, and strong stakeholder relationships within the healthcare ecosystem.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic Plc
• Abbott Laboratories
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Cook Medical
• AngioDynamics, Inc.
• Cordis Corporation
• Asahi Intecc Co., Ltd.
• Penumbra, Inc.
• Edward Lifesciences Corporation
• Stryker Corporation
• BD (Becton, Dickinson and Company)
• LivaNova PLC
• Atricure, Inc.

The overall competitive landscape of the occlusion devices market is characterized by a mix of established players and emerging companies, each vying for market share through innovation and strategic partnerships. The leading companies are investing significantly in research and development to advance their product offerings and meet the evolving needs of healthcare providers. These companies are also engaging in mergers and acquisitions to expand their portfolios and enhance their competitive positions. Additionally, the focus on developing minimally invasive solutions is prompting players to collaborate with hospitals and surgical centers to better understand clinical needs and offer tailored products.

Boston Scientific Corporation is one of the key players in the occlusion devices market, known for its extensive range of medical devices, including occlusion balloons and coils. The company emphasizes innovation and quality, which has positioned it as a trusted name among healthcare providers. Medtronic Plc is another major competitor, with a strong presence in the vascular intervention market. Their commitment to advancing medical technology and improving patient outcomes has led to the development of several groundbreaking occlusion solutions. Abbott Laboratories and Terumo Corporation are also notable players, offering a diverse portfolio of products aimed at addressing various therapeutic needs in the occlusion devices space.

New entrants and smaller companies are emerging in the occlusion devices market, bringing fresh ideas and innovative solutions. Startups focusing on bioabsorbable and liquid embolic technologies are gaining traction as they align with the growing demand for safer and more effective occlusion methods. These companies are leveraging emerging technologies and agile business models to carve out their niche in the market, challenging established players and driving overall market growth. In this dynamic landscape, the ability to adapt to regulatory changes, technological advancements, and shifting market demands will be crucial for companies aiming to succeed in the competitive occlusion devices market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cook Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 LivaNova PLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic Plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Atricure, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Penumbra, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Cordis Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 AngioDynamics, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Asahi Intecc Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Boston Scientific Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 W. L. Gore & Associates, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Edward Lifesciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Occlusion Devices Market, By Application
    • 6.1.1 Neurology
    • 6.1.2 Cardiology
    • 6.1.3 Oncology
    • 6.1.4 Peripheral Vascular Disease
    • 6.1.5 Others
  • 6.2 Occlusion Devices Market, By Product Type
    • 6.2.1 Occlusion Balloons
    • 6.2.2 Occlusion Coils
    • 6.2.3 Occlusion Plugs
    • 6.2.4 Vascular Clips
    • 6.2.5 Liquid Embolics
  • 6.3 Occlusion Devices Market, By Material Type
    • 6.3.1 Polymer
    • 6.3.2 Metal
    • 6.3.3 Bioabsorbable
    • 6.3.4 Liquid
    • 6.3.5 Others
  • 6.4 Occlusion Devices Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Catheterization Labs
    • 6.4.5 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Occlusion Devices Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Occlusion Devices market is categorized based on

By Product Type

• Occlusion Balloons
• Occlusion Coils
• Occlusion Plugs
• Vascular Clips
• Liquid Embolics

By Application

• Neurology
• Cardiology
• Oncology
• Peripheral Vascular Disease
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Catheterization Labs
• Online Sales

By Material Type

• Polymer
• Metal
• Bioabsorbable
• Liquid
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Medtronic Plc
• Abbott Laboratories
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Cook Medical
• AngioDynamics, Inc.
• Cordis Corporation
• Asahi Intecc Co., Ltd.
• Penumbra, Inc.
• Edward Lifesciences Corporation
• Stryker Corporation
• BD (Becton, Dickinson and Company)
• LivaNova PLC
• Atricure, Inc.